DWA
UTMD icon

Dorsey Wright & Associates’s Utah Medical Products UTMD Stock Holding History

Dorsey Wright & Associates’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-101
Closed -$9K – 365
2020
Q2 		$9K Hold
101
– – ﹤0.01% 288
2020
Q1 		$9K Sell
101
-10
-9% -$929 ﹤0.01% 172
2019
Q4 		$12K Buy
+111
New +$11.2K ﹤0.01% 207

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Dorsey Wright & Associates's UTMD Position: Q3 2020 in Review

Dorsey Wright & Associates sold out of Utah Medical Products (UTMD) in Q3 2020, closing a stake of 101 shares — an estimated $9K sold.

Dorsey Wright & Associates first reported a position in UTMD in Q4 2019 and held it in 3 quarters. The position peaked at $12K in Q4 2019. 85 funds tracked by Wall St. Rank hold UTMD as of Q3 2020.

  • Dorsey Wright & Associates reported no remaining Utah Medical Products position as of Q3 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 101 Utah Medical Products shares in Q3 2020, an estimated $9K.
  • Dorsey Wright & Associates first reported a position in Utah Medical Products in Q4 2019 and held it in 3 quarters.
  • Dorsey Wright & Associates's Utah Medical Products position peaked at $12K in Q4 2019.
  • 85 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2020.

Based on Dorsey Wright & Associates's 13F filing for Q3 2020, filed 28 Oct 2020.